Related Experiment Videos

Reply to 'Economic comments on proposal for a novel cancer drug pricing model'

Carin A Uyl-de Groot^1,2, Bob Löwenberg³

¹Erasmus School of Health Policy & Management, Erasmus University Rotterdam, Rotterdam, Netherlands. uyl@eshpm.eur.nl.

Nature Reviews. Clinical Oncology

|August 15, 2018

Abstract

No abstract available in PubMed .

Related Concept Videos

Articles linked to this work by shared authors, journal, and citation graph.

Autologous stem cell transplantation versus consolidation chemotherapy as postremission treatment in newly diagnosed favorable- and intermediate-risk patients with AML: A comparative analysis of HOVON-SAKK-Nordic trials.

HemaSphere·2026

Prognostic value of measurable residual disease in high-risk MDS after intensive chemotherapy in HOVON-SAKK studies.

HemaSphere·2026

From Genomic Testing to Olaparib Treatment: Real-World Utilization and Outcomes in BRCA-Mutated Metastatic Castration-Resistant Prostate Cancer.

Drugs - real world outcomes·2026

Involvement in the Shadows: A Qualitative Interview Study on Informal Caregiver Involvement in the Formal Care Trajectories of Individuals Living with Severe Mental Health Problems.

Community mental health journal·2026

Treatment of therapy-related acute myeloid leukemia and acute myeloid leukemia with myelodysplasia-related changes: a comparative analysis of higher-dose intensive 7+3 induction chemotherapy versus liposomal cytarabine and daunorubicin.

Haematologica·2026

Post-radiotherapy health utility and symptom trends in patients with non-metastatic head and neck cancer.

Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology·2026

See all related articles